NCT00287183
- Conditions
- Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, +8 more
- Locations
-
- Pfizer Investigational Site Red Deer, Alberta, Canada
- Pfizer Investigational Site Penticton, British Columbia, Canada
- Pfizer Investigational Site Vancouver, British Columbia, Canada
- Pfizer Investigational Site Burlington, Ontario, Canada